November 2017 FDA Recall Paroxetine by Zydus Pharmaceuticals Usa Inc
D-0101-2018 - Presence of Foreign Tablets/Capsules

This Class II drug recall was voluntarily initiated by Zydus Pharmaceuticals Usa Inc on November 20, 2017 for the product Paroxetine. The FDA reported the reason for recall as presence of foreign tablets/capsules. The product was distributed Nationwide and the recall is currently terminated.

Recall Number: D-0101-2018

Reason for Recall
Presence of Foreign Tablets/Capsules: Risperidone Tablets were found in bottle of Paroxetine Tablets
Initiated
11-20-2017
Reported
12-06-2017
Quantity
19812 bottles

Recall Profile & Regulatory Data

Class II - is a situation in which use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences or where the probability of serious adverse health consequences is remote
Zydus Pharmaceuticals USA Inc
Paroxetine Tablets USP, 30 mg, a) 30 count (NDC 68382-099-06), b) 500 count (NDC 68382-099-05), and c) 1000 count (NDC 68382-099-10) count bottles, Rx Only, Manufactured by: Cadila Healthcare Ltd, Ahmedabad, India Distributed by: Zydus Pharmaceuticals USA, Inc., Pennington, NJ 08534

Batch or Lot Expiration Information

Lot# a) Z701308, b) Z701309, c) Z701310 exp April 2019